Screening – AVATAR: THE WAY OF WATER in HFR 3D + Q&A (Los Angeles)
VES Members and One (1) Guest are Invited to an Opening Weekend 3D HFR Screening of Walt Disney Pictures’ and 20th Century Studios’ AVATAR: THE WAY OF WATER followed by a Q&A with the Filmmakers
Walt Disney Studios safety guidelines require that all VES members and guests must show photo ID that matches their names on the RSVP list and all unvaccinated attendees must wear masks at all times indoors.
Panelists will include VES Lifetime Achievement Award-winning Director-Writer-Producer-Editor James Cameron, Oscar winning Producer Jon Landau, Executive Producer, VES Award-winning Visual Effects Supervisor at Wētā FX Richard Baneham, VES Georges Méliès Award-winning Senior Visual Effects Supervisor at Wētā FX Joe Letteri, VES, Wētā Visual Effects Producer Lena Scanlan, VES Award-winning Head of FX at Wētā FX Johnathan Nixon and VES Award-winning Animation Supervisor at Wētā FX Eric Reynolds, moderated by VES Chair Lisa Cooke. (All panelists’ participation based on availability.)
RSVPs are closed
Saturday, December 17, 2022 at 11:00AM (Please arrive early to allow time for check-in)
Walt Disney Studios Main Theater
500 S. Buena Vista St., Burbank, CA 91521
(Please enter through the Alameda gate and park as directed.)
In an effort to prevent the spread of COVID-19, we ask that you or your guests do not attend VES events if you are experiencing any symptoms or if you have been exposed to the virus.
Screenings are overbooked to compensate for no-shows. Seating is limited and will be available on a first come, first served basis. An RSVP does not guarantee seating.
By signing up for this on-site, in-person screening/event sponsored by VES (Visual Effects Society), you willingly accept any potential inherent risks associated with COVID-19. VES cannot be held liable from any consequences that may transpire from said risk. Therefore, signing up for this screening/event infers implied consent of yourself and your party and hereby indemnifies and holds harmless VES, its directors, its employees and any other affiliated persons from any adverse medical or financial impact that may result from our participation.